Faïza Ajana

2.1k total citations
44 papers, 796 citations indexed

About

Faïza Ajana is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Faïza Ajana has authored 44 papers receiving a total of 796 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Infectious Diseases, 26 papers in Virology and 14 papers in Epidemiology. Recurrent topics in Faïza Ajana's work include HIV/AIDS drug development and treatment (28 papers), HIV Research and Treatment (25 papers) and HIV/AIDS Research and Interventions (17 papers). Faïza Ajana is often cited by papers focused on HIV/AIDS drug development and treatment (28 papers), HIV Research and Treatment (25 papers) and HIV/AIDS Research and Interventions (17 papers). Faïza Ajana collaborates with scholars based in France, United States and Belgium. Faïza Ajana's co-authors include Brian Wynne, Mounir Ait‐Khaled, Jonathan Wright, Jean van Wyk, Keith A. Pappa, Ruolan Wang, Fiona Bisshop, Michael Aboud, Christoph Wyen and Olayemi Osiyemi and has published in prestigious journals such as Clinical Infectious Diseases, The American Journal of Medicine and The Journal of Infectious Diseases.

In The Last Decade

Faïza Ajana

42 papers receiving 784 citations

Peers

Countries citing papers authored by Faïza Ajana

Since Specialization

Citations

This map shows the geographic impact of Faïza Ajana's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Faïza Ajana with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Faïza Ajana more than expected).

Fields of papers citing papers by Faïza Ajana

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Faïza Ajana. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Faïza Ajana. The network helps show where Faïza Ajana may publish in the future.

Co-authorship network of co-authors of Faïza Ajana

This figure shows the co-authorship network connecting the top 25 collaborators of Faïza Ajana. A scholar is included among the top collaborators of Faïza Ajana based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Faïza Ajana. Faïza Ajana is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Switch to bictegravir/emtricitabine/tenofovir alafenamide in people living with HIV aged 65 years or older: BICOLDER study – IMEA 057 2025 ·Journal of Infection and Public Health ·Minh Lê, Clotilde Allavena, Véronique Joly, Lambert Assoumou, Valentina Isernia, Faïza Ajana, D. Neau, Diane Descamps, Charlotte Charpentier, (unknown), Bao Phung, Gilles Peytavin, Roland Landman	0
2	Once-daily dolutegravir versus darunavir plus cobicistat in adults at the time of primary HIV-1 infection: the OPTIPRIM2-ANRS 169 randomized, open-label, Phase 3 trial 2022 ·Journal of Antimicrobial Chemotherapy ·Antoine Chéret, Rebecca Bauer, Vincent Meiffrédy, (unknown), Faïza Ajana, Karine Lacombe, Philippe Morlat, C. Lascoux, Jacques Reynes, Ruxandra Câlin, Sylvie Abel, Cécile Goujard, Christine Rouzioux, Véronique Avettand-Fènoël, Laurence Meyer	7
3	Hypogonadism: a neglected comorbidity in young and middle-aged HIV-positive men on effective combination antiretroviral therapy 2022 ·AIDS ·Marie Lachâtre, A. Pasquet, Faïza Ajana, Benoı̂t Soudan, Yann Quertainmont, Georges Lion, Emmanuel Durand, Laurence Bocket, M.Leonard Mole, Pauline Cornavin, (unknown), É. Senneville, Cécile Goujard, Faroudy Boufassa, Antoine Chéret	6
4	Virological Outcome After Choice of Antiretroviral Regimen Guided by Proviral HIV-1 DNA Genotyping in a Real-Life Cohort of HIV-Infected Patients 2020 ·AIDS Patient Care and STDs ·Agnès Meybeck, Enagnon Kazali Alidjinou, Thomas Huleux, Anne Boucher, (unknown), P. Choisy, Laurence Bocket, Faïza Ajana, Olivier Robineau	12
5	Clinical impact of tropism testing in a real-life cohort of HIV infected patients: a retrospective observational study 2019 ·BMC Infectious Diseases ·Laurène Deconinck, Olivier Robineau, M. Valette, P. Choisy, Laurence Bocket, Agnès Meybeck, Faïza Ajana	0
6	Severe toxoplasmosis imported from tropical Africa in immunocompetent patients: A case series 2019 ·Travel Medicine and Infectious Disease ·Jordan Leroy, Sandrine Houzé, Marie‐Laure Dardé, Hélène Yera, Benjamín Rossi, Laurence Delhaès, Frédéric Gabriel, Paul Loubet, (unknown), É. Senneville, Faïza Ajana, Boualem Sendid, Denis Malvy	14
7	Reduced bone mineral density among HIV-infected, virologically controlled young men 2018 ·AIDS ·(unknown), A. Pasquet, Cécile Goujard, Georges Lion, Emmanuel Durand, (unknown), Marie Lachâtre, P. Choisy, Faïza Ajana, Katia Bourdic, N. Viget, (unknown), Yann Quertainmont, Bernard Cortet, Faroudy Boufassa, Antoine Chéret	19
8	Vaccination Against Hepatitis B Virus (HBV) in HIV-1–Infected Patients With Isolated Anti–HBV Core Antibody: The ANRS HB EP03 CISOVAC Prospective Study 2016 ·The Journal of Infectious Diseases ·Lionel Piroth, Odile Launay, Marie‐Louise Michel, Abderrahmane Bourredjem, Patrick Miailhes, Faïza Ajana, Catherine Chirouze, David Zucman, Marie-Josée Wendling, Dani Nazzal, Fabrice Carrat, David Rey, Christine Binquet	23
9	HIV and hypogonadism 2016 ·AIDS ·Marie Lachâtre, A. Pasquet, Faïza Ajana, Benoı̂t Soudan, Georges Lion, Laurence Bocket, Pauline Cornavin, É. Senneville, Faroudy Boufassa, Antoine Chéret	17
10	Fluctuating Anaemia in Treated HIV Patients: Could be a PICA? 2013 ·Therapies ·Faïza Ajana, A. Pasquet, Marine Auffret, Sophie Gautier	1
11	Safety and Immunogenicity of a Monovalent 2009 Influenza A/H1N1v Vaccine Adjuvanted With AS03A or Unadjuvanted in HIV-Infected Adults: A Randomized, Controlled Trial 2011 ·The Journal of Infectious Diseases ·Odile Launay, Corinne Desaint, Christine Durier, Pierre Loulergue, Xavier Duval, Christine Jacomet, Gilles Pialoux, Jade Ghosn, F. Raffi, David Rey, Faïza Ajana, Nathalie Verdière, Jacques Reynes, Valérie Foubert, François Roman, Jeanne‐Marie Devaster, Jean‐François Delfraissy, J Aboulker	43
12	Lopinavir/ritonavir resistance in patients infected with HIV‐1: two divergent resistance pathways? 2011 ·Journal of Medical Virology ·Karen Champenois, (unknown), P. Choisy, Faïza Ajana, (unknown), Laurence Bocket, Yazdan Yazdanpanah	6
13	Newer drugs and earlier treatment 2011 ·AIDS ·Caroline E. Sloan, Karen Champenois, P. Choisy, Elena Losina, Rochelle P. Walensky, Bruce R. Schackman, Faïza Ajana, (unknown), A. David Paltiel, Kenneth A. Freedberg, Yazdan Yazdanpanah	65
14	Antibodies to tetanus, diphtheria and pertussis among healthy adults vaccinated according to the French vaccination recommendations 2009 ·Human Vaccines ·Odile Launay, (unknown), Claire Bernède, Elisabeth Njamkepo, Karine Petitprez, (unknown), (unknown), Catherine Goujon, Marie‐Noëlle Ungeheuer, Faïza Ajana, Christian Raccurt, J. Beytout, Christian Chidiac, Damien Bouhour, Didier Guillemot, Nicole Guiso	41
15	Natural polymorphisms in HIV‐1 protease: Impact on effectiveness of a first‐line lopinavir‐containing antiretroviral therapy regimen 2008 ·Journal of Medical Virology ·Karen Champenois, Sylvie Deuffic‐Burban, Laurent Cotte, Patrice André, P. Choisy, Faïza Ajana, Laurence Bocket, Yazdan Yazdanpanah	9
16	Increased bleeding in HIV-positive haemophiliac patients treated with lopinavir–ritonavir 2003 ·AIDS ·Yazdan Yazdanpanah, N. Viget, Antoine Chéret, (unknown), Y Gérard, Faïza Ajana, (unknown), Y Mouton	4
17	Hyperlactataemia During Antiretroviral Therapy: Incidences, Clinical Data and Treatment 2003 ·Therapies ·Y Gérard, N. Viget, Yazdan Yazdanpanah, Faïza Ajana, X. de la Tribonnière, Laurence Bocket, Sylvie Deuffic‐Burban, (unknown), (unknown), Y Mouton	8
18	Isolated cutaneous Mycobacterium avium complex infection in AIDS 1997 ·International Journal of Dermatology ·S. Alfandari, Faïza Ajana, (unknown), Éric Delaporte, Christian Chidiac, Y Mouton	1
19	Plasma levels of sTNFR p75 and IL-8 in patients with HIV-1 infection 1996 ·Immunology Letters ·Didier Hober, Samira Benyoucef, (unknown), Donat De Groote, Faïza Ajana, Y Mouton, P Wattré	6
20	A multicenter study of lomefloxacin and trimethoprim/sulfamethoxazole in the treatment of uncomplicated acute pyelonephritis 1992 ·The American Journal of Medicine ·Y Mouton, Faïza Ajana, Christian Chidiac, (unknown), (unknown), (unknown)	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact